Cargando…

TGF-β induces GBM mesenchymal transition through upregulation of CLDN4 and nuclear translocation to activate TNF-α/NF-κB signal pathway

Glioblastoma (GBM) is the most common and aggressive primary malignant brain tumor. The unregulated expression of Claudin-4 (CLDN4) plays an important role in tumor progression. However, the biological role of CLDN4 in GBM is still unknown. This study aimed to determine whether CLDN4 mediates glioma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Tengfeng, Tan, Yinqiu, Deng, Gang, Sun, Zhiqiang, Liu, Baohui, Wang, Yixuan, Yuan, Fanen, Sun, Qian, Hu, Ping, Gao, Lun, Tian, Daofeng, Chen, Qianxue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008023/ https://www.ncbi.nlm.nih.gov/pubmed/35418179 http://dx.doi.org/10.1038/s41419-022-04788-8

Ejemplares similares

FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma
por: Yan, Tengfeng, et al.
Publicado: (2022)

Small GTPase RHOE/RND3, a new critical regulator of NF‐κB signalling in glioblastoma multiforme?
por: Sun, Qian, et al.
Publicado: (2019)

Rho family GTPase 1 (RND1), a novel regulator of p53, enhances ferroptosis in glioblastoma
por: Sun, Qian, et al.
Publicado: (2022)

SAA1 knockdown promotes the apoptosis of glioblastoma cells via downregulation of AKT signaling
por: Zhang, Huikai, et al.
Publicado: (2021)

Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis
por: Zhang, Chunyu, et al.
Publicado: (2021)

Betulinic acid self-assembled nanoparticles for effective treatment of glioblastoma
por: Li, Yong, et al.
Publicado: (2022)

Weighted gene correlation network analysis identifies microenvironment-related genes signature as prognostic candidate for Grade II/III glioma
por: Li, Yong, et al.
Publicado: (2020)

Identification of differentially expressed key genes between glioblastoma and low-grade glioma by bioinformatics analysis
por: Xu, Yang, et al.
Publicado: (2019)

Identification of Immunogenic Cell Death-Related Signature for Glioma to Predict Survival and Response to Immunotherapy
por: Sun, Zhiqiang, et al.
Publicado: (2022)

Circulating Tumor Cells for Glioma
por: Zhang, Huikai, et al.
Publicado: (2021)

ADPRH is a prognosis-related biomarker and correlates with immune infiltrates in low grade glioma
por: Zhang, Chunyu, et al.
Publicado: (2021)

Notch intracellular domain regulates glioblastoma proliferation through the Notch1 signaling pathway
por: Wang, Yixuan, et al.
Publicado: (2021)

Genetic deletion of Rnd3 suppresses apoptosis through NF-κB signaling in the brain
por: Dong, Huimin, et al.
Publicado: (2021)

AKT Inhibitor SC66 Inhibits Proliferation and Induces Apoptosis in Human Glioblastoma Through Down-Regulating AKT/β-Catenin Pathway
por: Gao, Lun, et al.
Publicado: (2020)

Immunomodulatory Effects of Tryptophan Metabolism in the Glioma Tumor Microenvironment
por: Xu, Yang, et al.
Publicado: (2021)

The New PI3K/mTOR Inhibitor GNE-477 Inhibits the Malignant Behavior of Human Glioblastoma Cells
por: Wang, Yixuan, et al.
Publicado: (2021)

Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma
por: Zhang, Zhenfa, et al.
Publicado: (2013)

Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas
por: Ye, Liguo, et al.
Publicado: (2021)

The Expression of CLDN6 in Hepatocellular Carcinoma Tissue and the Effects of CLDN6 on Biological Phenotypes of Hepatocellular Carcinoma Cells
por: Lu, Yan, et al.
Publicado: (2021)

LRIG1 Enhances Chemosensitivity by Modulating BCL-2 Expression and Receptor Tyrosine Kinase Signaling in Glioma Cells
por: Guo, Zhentao, et al.
Publicado: (2014)

Identifying circulating glioma cells and their clusters as diagnostic markers by a novel detection platform
por: Qi, Yangzhi, et al.
Publicado: (2021)

The dual role of p62 in ferroptosis of glioblastoma according to p53 status
por: Yuan, Fanen, et al.
Publicado: (2022)

Hsa_circ_0072309 enhances autophagy and TMZ sensitivity in glioblastoma
por: Yuan, Fanen, et al.
Publicado: (2022)

Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications
por: Kwon, Mi Jeong, et al.
Publicado: (2010)

Association of CLDN6 and CLDN10 With Immune Microenvironment in Ovarian Cancer: A Study of the Claudin Family
por: Gao, Peipei, et al.
Publicado: (2021)

TNF-α and RANKL promote osteoclastogenesis by upregulating RANK via the NF-κB pathway
por: Luo, Gang, et al.
Publicado: (2018)

TMEM2 induces epithelial-mesenchymal transition and promotes resistance to temozolomide in GBM cells
por: Gao, Lun, et al.
Publicado: (2023)

RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting the p38 MAPK signalling pathway
por: Xu, Yang, et al.
Publicado: (2020)

Glioma Stem Cell-Targeted Dendritic Cells as a Tumor Vaccine Against Malignant Glioma
por: Ji, Baowei, et al.
Publicado: (2013)

Specification of the NF-κB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKKε
por: Moreno, Rita, et al.
Publicado: (2010)

Identification of glioblastoma gene prognosis modules based on weighted gene co-expression network analysis
por: Xu, Pengfei, et al.
Publicado: (2018)

HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma
por: Qi, Yangzhi, et al.
Publicado: (2019)

HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma
por: Qi, Yangzhi, et al.
Publicado: (2022)

The IL1β-HER2-CLDN18/CLDN4 axis mediates lung barrier damage in ARDS
por: Ma, Xinhua, et al.
Publicado: (2020)

Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
por: McDermott, Martina S.J., et al.
Publicado: (2023)

Kiaa0101 serves as a prognostic marker and promotes invasion by regulating p38/snail1 pathway in glioma
por: Liu, Junhui, et al.
Publicado: (2021)

BIRB796, an Inhibitor of p38 Mitogen-Activated Protein Kinase, Inhibits Proliferation and Invasion in Glioblastoma Cells
por: Zhao, Linyao, et al.
Publicado: (2021)

TMBIM1 promotes proliferation and attenuates apoptosis in glioblastoma cells by targeting the p38 MAPK signalling pathway
por: Cai, Jiayang, et al.
Publicado: (2022)

TNFα sensitizes hepatocytes to FasL-induced apoptosis by NFκB-mediated Fas upregulation
por: Faletti, Laura, et al.
Publicado: (2018)

Adipose Tissue Caveolin-1 Upregulation in Obesity Involves TNF-α/NF-κB Mediated Signaling
por: Al Madhoun, Ashraf, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cq56jqsht86k3kvqpessd3fpoa